Cilostazol vs placebo: Amputation
- Population
- intermittent claudication
- Intervention
- Cilostazol
- Comparison
- placebo
- Outcome
- Amputation
It is very uncertain whether cilostazol changes amputation (number of cases) compared with placebo (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Cilostazol vs placebo Amputation (number of cases) · intermittent claudication It is very uncertain whether cilostazol changes amputation (number of cases) compared with placebo (very low certainty). Cilostazol for intermittent claudication (2021) · Cochrane Headline outcomes only | OR 0.16 [0.01, 4.07] | 1 study · 516 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Cilostazol for intermittent claudication 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Cilostazol vs pentoxifylline · intermittent claudication · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.